Work

Measurable residual disease testing in acute myeloid leukaemia

Year: 2017

Type: article

Source: Leukemia

DOI: 10.1038/leu.2017.113

Authors: C S Hourigan, R P Gale, N J Gormley, G J Ossenkoppele, R B Walter

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, Imperial College London, United States Food and Drug Administration, Center for Drug Evaluation and Research, Amsterdam UMC Location Vrije Universiteit Amsterdam, University of Washington, Fred Hutch Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Wayne State University, National Institute for Health and Care Research, University of Oxford, National Institutes of Health, National Heart, Lung, and Blood Institute

OpenAlex ID: W2604474002

FWCI: 20.64

Cites: 148

Cited by: 235

Related to: 10